STOCK TITAN

OraSure (OSUR) CEO gets major stock awards, shares withheld for taxes

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

OraSure Technologies President & CEO Carrie Eglinton Manner reported equity compensation and related tax withholding transactions in company common stock. On March 2, 2026, she received a grant of 355,464 shares of restricted stock that vest in three equal annual installments beginning March 2, 2027, conditioned on continued service.

On March 1, 2026, she acquired 129,032 shares delivered in settlement of vested performance units and had 56,116 and 122,655 shares withheld at $3.0425 per share to cover tax liabilities tied to vesting of performance units and restricted shares. After these transactions, she directly owned 2,136,552 common shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
EGLINTON MANNER CARRIE

(Last) (First) (Middle)
C/O ORASURE TECHNOLOGIES, INC.
220 EAST FIRST STREET

(Street)
BETHLEHEM PA 18015

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ORASURE TECHNOLOGIES INC [ OSUR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/01/2026 A 129,032(1) A $0 1,959,859 D
Common Stock 03/01/2026 F 56,116(2) D $3.0425 1,903,743 D
Common Stock 03/01/2026 F 122,655(3) D $3.0425 1,781,088 D
Common Stock 03/02/2026 A 355,464(4) A $0 2,136,552 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares delivered in settlement of vested performance units that did not constitute a derivative security.
2. Withholding of shares to pay tax liability associated with the vesting of performance units.
3. Withholding of shares to pay the tax liability associated with vesting of restricted shares.
4. Grant of restricted stock award vesting in three equal annual installments beginning on March 2, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
/s/ Michele Anthony, Attorney-In-Fact 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did OraSure (OSUR) report for its CEO?

OraSure’s CEO reported stock awards and tax-related share withholdings. She received common shares from vested performance units and a new restricted stock grant, while shares were withheld to satisfy tax liabilities tied to vesting events, leaving her with a substantial direct ownership stake.

How many OraSure (OSUR) shares were granted to the CEO in this filing?

The CEO received a grant of 355,464 restricted shares. These shares vest in three equal annual installments beginning March 2, 2027, contingent on her continued service with the company, aligning a portion of her compensation with OraSure’s long-term performance.

Were any OraSure (OSUR) shares sold on the open market in this Form 4?

The disposition transactions reflect tax withholding, not open-market sales. Shares were withheld at $3.0425 per share to cover tax liabilities from vesting of performance units and restricted shares, a common mechanism in equity compensation programs rather than discretionary selling.

What is the vesting schedule for the new OraSure (OSUR) restricted stock award?

The new restricted stock award vests in three equal annual installments starting March 2, 2027. Each anniversary date releases one-third of the 355,464 granted shares, provided the CEO maintains continuous service with OraSure Technologies through the respective vesting dates.

How many OraSure (OSUR) shares does the CEO own after these transactions?

Following the reported equity grant and tax-related withholdings, the CEO directly owns 2,136,552 OraSure common shares. This total reflects her updated beneficial ownership position immediately after the transactions disclosed in the Form 4 insider filing.

What was the purpose of the OraSure (OSUR) tax-withholding share dispositions?

Shares were withheld to pay tax liabilities related to vesting equity awards. Specifically, vested performance units and restricted shares triggered taxes, and 56,116 plus 122,655 shares were delivered at $3.0425 each to satisfy those obligations instead of paying cash.
Orasure Tech

NASDAQ:OSUR

OSUR Rankings

OSUR Latest News

OSUR Latest SEC Filings

OSUR Stock Data

214.12M
67.32M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BETHLEHEM